Samenvatting
Artsen, en steeds vaker ook assistent-artsen (vaker in Nederland aangeduid als physician assistants), casemanagers en specialistisch verpleegkundigen werkzaam op het terrein van dementiezorg, hebben nadrukkelijk te maken met geneesmiddelen wanneer zij patiënten met dementie begeleiden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatuur
Glind EM van de, Enst WA van, Munster BC van, et al. Pharmacological treatment of dementia: a scoping review of systematic reviews. Dement Geriatr Cogn Disord. 2013;36:211-28.
Hort J, O’Brien JT, Gainotti G, et al.; efns Scientist Panel on Dementia. efns guidelines for the diagnosis and management of Alzheimer’s disease. Eur J Neurol. 2010;717:1 236-48.
American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer’s disease and other dementias of late life. Am J Psychiatry. 1997;154:S1-39.
Cummings J. Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher dose rivastigmine patch (15 vs. 10 cm) in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;33:341-53
Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev. 2012;3:CD006504.
Roman GC. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke. 2010;41:1213-21.
nice. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. nice technology appraisal guidance 217 (review of nice technology appraisal guidance 111), 2011.
Farrimond LE, Roberts E, McShane R. Memantine and cholinesterase inhibitor combination therapy for Alzheimer’s disease: a systematic review. BMJ Open. 2012;2.
Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med. 2012;366:893-903.
Ojik AL van, Jansen PAF, Brouwers JRBJ, Roon EN van. Antipsychotica. Geneesmiddelbeoordeling voor de kwetsbare oude patiënt. Farmacotherapeutisch Kompas. 2013.
Spek K van der, Gerritsen DL, Smalbrugge M, et al. proper i: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol. bmc Psychiatry. 2013;13:307.
Antipsychotica bij probleemgedrag in het verpleeg- en verzorgingshuis. Geneesmiddelen Bull. februari 2013.
Smalbrugge M, Boessma F, Kleijer BC, et al. Richtlijn Probleemgedrag (met herziene medicatieparagraaf). Utrecht: Verenso, 2008.
Relevante websites
http://richtlijnendatabase.nl> richtlijn dementie.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Bohn Stafleu van Loghum, onderdeel van Springer Media B.V.
About this chapter
Cite this chapter
Koopmans, R., Rikkert, M.O., Zuidema, S. (2018). Medicamenteuze behandeling van dementie. In: Dröes, RM., Scheltens, P., Schols, J. (eds) Meer kwaliteit van leven. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-368-2048-6_3
Download citation
DOI: https://doi.org/10.1007/978-90-368-2048-6_3
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-368-2047-9
Online ISBN: 978-90-368-2048-6
eBook Packages: Dutch language eBook collection